HTG Molecular Diagnostics HTGM reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
HTG Molecular Diagnostics beat estimated earnings by 10.0%, reporting an EPS of $-0.54 versus an estimate of $-0.6.
Revenue was down $582 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 0.34% increase in the share price the next day.
Here’s a look at HTG Molecular Diagnostics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.71 | -0.59 | -0.66 | -0.77 |
| EPS Actual | -0.81 | -0.69 | -0.60 | -0.65 |
| Revenue Estimate | 2.15M | 2.97M | 2.65M | 2.13M |
| Revenue Actual | 1.18M | 2.88M | 2.52M | 2.07M |
To track all earnings releases for HTG Molecular Diagnostics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.